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Background: Obesity is known to induce a state of lipotoxicity that affects the 
different organs of the body. Metformin is an antidiabetic drug commonly used in 
obesity treatment. It was known to improve thyroid function and its regulating 
hormones. Structural changes in the thyroid gland associated with obesity were not 
investigated well. So, the aim of the present study is to detect structural changes in 
thyroid gland induced by obesity and to investigate the possible protective role of 
metformin therapy. 
Materials and methods: Thirty adult female albino rats were divided into three 
groups (10 rats each). Group I (control group), group II (rats fed with a high-fat diet), 
and group III (rats fed with a high-fat diet and received metformin therapy). After 12 
weeks, rats from all groups were sacrificed. Blood samples were taken for 
measurement of lipid profile, TSH, free T3 and free T4. Thyroid glands were 
extracted & processed for histological & ultrastructural study. Morphometric 
measurements for the colloid area of thyroid follicles and height of the follicular cells 
were done. 
Results: Group I displayed normal biochemical parameters and architecture of the 
thyroid gland. Group II revealed disordered lipid profile, high TSH, free T3 and T4. 
Microscopically, large thyroid follicles with excessive colloid accumulation and 
decreased follicular cells height. Some follicular cells showed pyknotic nuclei, 
vacuolated cytoplasm and disrupted basement membrane with mast cell infiltration of 
the thyroid tissue. Ultra-structurally, group II follicular cells showed loss of apical 
microvilli, dense shrunken nuclei, dilated endoplasmic reticulum, swollen damaged 
mitochondria with large intracellular vacuoles and colloid droplets. In group III, the 
biochemical parameters and structure of thyroid follicles were improved, and they had 
a near-normal appearance.  
Conclusions: Obesity induced by high-fat diet in female rats structurally and 
functionally changed the thyroid gland in a way that may explain hypothyroidism 
associated with obesity. These changes were improved by metformin therapy.  




Nowadays, obesity is a major dilemma for all the health workers over the 
globe and becomes a leading cause of many diseases as cardiovascular diseases, 
diabetes, and cancer [32] with significant multiple endocrine systems affection [6] 
including thyroid dysfunction [9]. Obesity is characterized by secretion of diverse 
inflammatory cytokines from adipose tissue as tumour necrosis factor-alpha (TNF-α) 
and interleukins 1&6 that reach the blood and lead to decreased iodide uptake by 
thyroid cells in rats and humans with secondary increase in thyroid stimulating 
hormone (TSH) level [2] & [38].  
Genetic and environmental factors play a role in the aetiology of obesity, and 
diet is one of the main environmental factors that contribute to this disease. Numerous 
researches on human have shown that increased fat consumption is associated with 
body weight gain which can lead to multiple metabolic diseases and obesity. 
Routinely, animal rodent models are valuable tools for studying obesity and its related 
disorders as they can rapidly gain weight when fed by high-fat diet (HFD) [8] & [20]. 
The thyroid gland synthesizes thyroid hormones that play a crucial role in 
metabolism and in the development, differentiation, and maintenance of the skeletal, 
cardiovascular and nervous systems [46]. The production and secretion of the 
hormones by the thyroid gland are directly regulated by the hypothalamus-pituitary-
thyroid axis [29]. The pituitary gland serves as a biosensor of thyroid hormone levels. 
It secretes TSH in blood according to the feedback of FT4 (free thyroxine) and FT3 
(free triiodothyronine). Worldwide, thyroid diseases especially hypothyroidism have 
attained epidemic proportions although the causes for the enhanced prevalence of the 
thyroid disorders remain unclear [42]. 
Metformin is one of the commonly used antidiabetic drugs over many years 
[11]. Metformin could affect (TSH) levels without affecting thyroid hormones levels 
[17]. Also, it decreased thyroid volume and size of its nodules in patients with insulin 
resistance [4]. It was found to have a direct anti-proliferative action on the thyroid 
gland through inhibiting mammalian target of rapamycin (mTOR) activity [15]. Like 
surgery, metformin therapy in obese diabetic persons normalized high (TSH) levels 
[36]. Study of the histological changes of the thyroid gland with obesity was very 
limited up till now. So, the aim of the present study was to detect the structural 
changes of the thyroid gland in obese female rats and to evaluate the possible role of 
metformin therapy.  
MATERIALS AND METHODS 
Animals 
Thirty adult female albino rats aged 5-7 months were selected for the current 
study, their weight was 150–180 g. This study was performed in the Medical 
Research Center, Faculty of Medicine, Ain Shams University. For seven days, the 
animals were maintained under strict sterile conditions with unrestricted access to 
food and water and 12/12h light and dark cycle. All the procedures of the experiment 
were carried out according to the guide rules of the Committee of the Animal 
Research Ethics (CARE), Faculty of Medicine, Ain Shams University.  
Experimental design 
The rats were separated into three groups: 
— Group I (the control group) (n=10): rats in this group were nourished a standard 
chow diet for twelve weeks. 
— Group II (model of obesity) (n=10): rats in this group were nourished a HFD for 
twelve weeks for induction of obesity and received distilled water orally in the last 
four weeks of the study (weeks 9–12) [39].  
— Group III (n=10): Rats in this group were nourished a HFD for twelve weeks and 
received metformin orally (100 mg/kg/day) [48] in the last four weeks of the study 
(weeks 9–12). 
Measurements of waist circumference and body weight of the rats were done 
weekly. After 12 weeks, anesthetization of animals was done, blood samples were 
obtained by puncturing of the hearts and the sera were used for biochemical 
examinations and then they were sacrificed. The thyroid glands were extracted from 
all animals, washed in saline, and then prepared for histological study (light and 
electron microscopic study). 
 
Biochemical investigations 
1) Serum lipid profile 
Estimation of serum concentrations of total cholesterol (TC) and triglyceride 
(TG) were done by the colorimetric method using commercial kits (Biolabo-France). 
HDL-cholesterol was assayed by ELISA kits (Bioassay Technology Laboratory, 
China) (Acikel et al., 2019), and LDL-cholesterol was measured using the Friedewald 
equation [35]. 
2) Serum thyroid hormones 
Serum levels of FT3, FT4, total T3, and TSH were measured using a 
competitive electrochemiluminescence immunoassay on the Roche E Modular system 
(Roche Diagnostics, Indianapolis, IN). 
Diet 
(a) Standard chow diet was purchased from Meladco for Animal Food, El-Obour, 
Egypt. It consisted of 20% protein, 4% fat, 70% carbohydrates, 3% fibers, 1% 
vitamins, and 2% mineral salts in the form of pellets. 
(b) The HFD was a blend of chow pellets (72.8 %), cholesterol white powder (Sigma-
Aldrich Chemicals, Germany) (2%), commercial lard liquid oil (25%) & bile salts 
(Sigma-Aldrich Chemicals) brown powder (0.2%). This mixture was formed every 
week forming pellets that were dried and kept in a fridge [39].   
Tissue preparation for histological study 
The thyroid glands of all rats were cut to small parts (3mm thick) and fixed in 
a solution formed of 2.5% paraformaldehyde and 2.5% glutaraldehyde for twenty-four 
hours at 4°C. Post-fixation was done in 1% osmium tetroxide and dehydration in 
rising grades of alcohol. Then the taken tissue pieces were dropped in two changes of 
propylene oxide to be finally fixed in epon. Semi-thin sections (1 µm thickness) were 
prepared and stained with 1% toluidine blue and inspected with the light microscope. 
Then ultra-thin sections (60 nm thickness) were cut, mounted on copper grids and 
stained with uranyl acetate and lead citrate. The grids were then inspected with the 
transmission electron microscope (Seo- Russia) in Faculty of Science; Ain-Shams 
University, Cairo [37]. 
Morphometric study 
Ten non-overlapping high-power fields (x400) per each group, in the toluidine 
blue stained semithin slides were examined. The images of the three groups were 
taken by a Nikon microscope connected with Nikon camera. The follicular epithelial 
height and colloid area of thyroid follicles were measured in pixel and pixel [22] 
respectively using Digimizer software program version 4.6.1.  
Statistical analysis 
The obtained data were evaluated using SPSS software version 20 (SPSS Inc. 
Chicago, USA). One-way ANOVA test was selected to compare between the 
follicular epithelial height and colloid area of thyroid follicles in the different studied 
groups. Values gained were stated as means ±standard deviation (SD) and differences 
with P < 0.05 were considered to be statistically significant.    
RESULTS 
Body weight and waist circumference 
There was progressively increasing weight gain in groups (I) & (II) over the 
12 weeks of the study with a statistically significant higher weight gain in group (II) 
than group (I). Group (III) displayed progressively increasing weight gain similar to 
group (I) till 8th week of the study. Thereafter, there was abrupt marked decrease in 
body weight in group (III) rats (Fig. 1A). At the end of the experiment, group (II) had 
an extremely statistically significant higher weight gain than group (I) (P ˂ 0.0001), 
meanwhile, group (III) had an extremely statistically significant lower weight gain 
than both groups (I&II) (P ˂ 0.0001) (Table I, Fig. 1B). 
Lipid profile 
Serum concentrations of all lipids (total cholesterol, TG, HDL and LDL) were 
markedly increased in group (II) with an extremely statistically significant difference 
as compared to group (I). Group (III) displayed reduction of serum concentrations of 
all lipids with an extremely statistically significant difference as compared to group 
(II) (Table I, Fig. 1C). 
Hormonal profile 
Serum free T3 was diminished in group (II) with a statistically significant 
difference (P = 0.0305) as compared to group (I), meanwhile, group (III) displayed a 
marked rise of free T3 with an extremely statistically significant difference as 
compared to group (II). Serum free T4 was markedly reduced in group (II) with an 
extremely statistically significant difference (P ˂ 0.0001) as compared to group (I), 
meanwhile, there was a marked rise of free T4 in group (III) with an extremely 
statistically significant difference (P ˂ 0.0001) as compared to group (II). Serum TSH 
concentration was markedly increased in group (II) with an extremely statistically 
significant difference (P ˂ 0.0001) as compared to group (I), on the contrary, it was 
markedly reduced in group (III) with an extremely statistically significant difference 
(P ˂ 0.0001) as compared to group (II) (Table I, Fig. 1D). 
Light microscopy 
1- Group (I) (control group) 
Thyroid gland revealed many thyroid follicles of variable size. Each follicle was 
lined by a single layer of cuboidal follicular cells with spherical vesicular nuclei, and 
a lumen filled with moderate amount of homogenous colloid (euthyroid appearance). 
The follicles were separated by capillary beds with flat endothelium. Normal 
parafollicular cells were encountered in the follicular cuboidal epithelium within the 
basement membrane and between follicles. They appeared as large cells with 
spherical vesicular nuclei and pale cytoplasm. Some inter-follicular cells were seen 
that may be tangentially cut follicles (Fig. 2A).  
2- Group (II) 
Thyroid gland of group (II) animals showed hypothyroid follicles of varying 
diameters, with a preponderance of large follicles (macro-follicles) exhibiting 
excessive amount of colloid. The follicular epithelial cells showed an apparent 
decrease in height and some of them were markedly flattened with flat and oval 
nuclei. The nuclei of some cells were also deeply stained, flat or shrunken i.e. 
pyknotic (Fig. 2B). The cytoplasm was vacuolated in some follicular cells, and the 
basement membrane was disrupted. Some parafollicular cells displayed pyknotic 
nuclei. There was a variation in the density of colloid between follicles and some 
follicles presented colloid vacuolation. The capillaries were compressed between the 
distended follicles and could be hardly seen. The inter-follicular connective tissue 
presented infiltration by mast cells (Fig. 2C). The mast cell infiltration involved also 
the loose connective tissue surrounding the thyroid gland (Fig. 2D). 
3- Group (III) 
Thyroid gland of metformin-treated animals (group III) showed a near-normal 
follicular structure. The follicular epithelial cells appeared cuboidal with spherical 
vesicular nuclei, but some cells were still flat with oval vesicular nuclei. The 
cytoplasm of few cells still showed vacuolations. The colloid was moderate in amount 
without vacuolation. Most of the parafollicular cells showed a near-normal structure 
with large spherical vesicular nuclei and pale cytoplasm. There was no variation in the 
density of colloid between follicles. The capillaries could be seen in-between the 
follicles (Fig. 3A). No mast cells infiltration could be observed in between the 
follicles and in the loose connective tissue surrounding the thyroid gland (Fig. 3B). 
Electron microscopy 
1- Group (I) (control group) 
Light microscopic findings were confirmed by electron microscopy. Thyroid 
follicular cells of group (I) rats appeared normal, resting on the basement membrane 
with prominent plasmalemma, euchromatic nuclei and apical microvilli protruding 
into the follicular lumen. The cytoplasm revealed mitochondria, moderately dilated 
endoplasmic reticulum, secretory granules varying in size, lysosomes, and ribosomes. 
The endothelium of blood capillaries could be detected (Fig.4A & B). 
The parafollicular cells of group (I) rats showed large euchromatic nuclei, 
numerous variably sized cytoplasmic granules, clusters of ribosomes, and 
mitochondria. They were present mainly adjacent to blood capillaries (Fig. 4C). 
2- Group (II) 
Thyroid follicular cells of group (II) rats showed significantly decreased cell 
height and flat or oval nuclei. There was markedly huge amount of colloid in the 
follicular lumen. Moreover, some follicles showed blunt apical surface with loss of 
apical microvilli (Fig. 5A). 
Some follicular cells showed irregular shrunken nuclei with dense chromatin, an 
apparent decrease in the number of ribosomes and secretory granules. Moreover, they 
demonstrated markedly dilated endoplasmic reticulum, large intracellular vacuoles, 
large colloid droplets and large pleomorphic lysosomes (Fig. 5B & C). 
Some mitochondria appeared swollen with damaged cristae, could be seen close to 
the dilated endoplasmic reticulum of the follicular cells (Fig. 5D). Some parafollicular 
cells appeared normal, but others showed irregular shrunken nuclei with dense 
chromatin, multiple intracellular vacuoles and mitochondria with damaged cristae 
(Fig. 5D). 
3- Group (III) 
Thyroid follicular cells of (group III), exhibited a near-normal structure. They had 
spherical euchromatic nuclei and the cytoplasm contained moderately dilated 
endoplasmic reticulum, healthy mitochondria, apical microvilli, rounded lysosomes, 
ribosomes, and secretory granules but few small vacuoles could be seen (Fig. 6A & 
B). 
Few follicular cells still had oval nuclei, moderately dilated endoplasmic 
reticulum and small vacuoles (Fig. 6C). The parafollicular cells of group (III) showed 
near-normal euchromatic nuclei with their characteristic multiple cytoplasmic 
granules (Fig. 6D). 
Morphometry 
Morphometric investigations revealed an extremely statistically significant 
increase in the colloid area in group (II) as compared to group (I). Moreover, there 
was a statistically significant reduction of the colloid area in group (III) as compared 
to group (II) [Table II, Fig. 7A].  
Meanwhile, there was a marked statistically significant reduction of the 
follicular cell height in group (II) as compared to group (I) and a statistically 
significant increase of the follicular cell height in group (III) as compared to group 
(II) [Table II, Fig. 7B].   
DISCUSSION 
Obese persons usually have hypertriglyceridemia [31]. Hypertriglyceridemia 
induces the aggregation of neutral lipids in non-adipose tissues. The lipid aggregates 
in cells lead to a chronic state of cellular injury and malfunction called lipotoxicity 
[25]. Recently, lipotoxicity has been considered as a cause of many metabolic 
diseases and it seriously and extensively harms human health [34] & [3].  
In the present study, HFD feeding induced a state of obesity in rats of group II. 
The biochemical results revealed a state of hypothyroidism (high TSH and low free 
T3 and T4) with disordered lipid profile (high TC, TG, HDL and LDL). Moreover, 
examination of the semithin sections of rats fed with HFD (group II) revealed thyroid 
follicles exhibiting excessive amounts of colloid and markedly flattened follicular 
cells. The morphometric analysis also revealed a notably statistically significant 
elevation in the colloid area and a markedly statistically significant decrease of the 
follicular cell height in group (II) as compared to group (I). These histo-
morphological alterations of the thyroid gland in rats fed with HFD were similar to 
the changes seen in the thyroid gland of hypothyroid rats [26]. Our observations were 
compatible with the study of (Shao et al, 2014) [42]. They observed flattened 
follicular cells and expanded follicles in the thyroid glands of rats fed with high fat-
lard diet. They also noted markedly reduced levels of total thyroxine (TT4), free 
thyroxine (FT4) and increased levels of (TSH) in the rats' sera. Furthermore, Han et 
al., (2012) [21] observed a similar histo-morphological alteration in mice. They 
proved that HFD in addition to excess iodine has a more severely injurious effect on 
thyroid gland than excess iodine alone. 
The aforementioned results in rats may be in harmony with the conclusions of 
(Biondi, 2010) [7] in humans. He stated that one may assume an association between 
obesity, leptin increase, (TSH) increase, the changes in thyroid structure and 
morphology, and the occurrence of overt and subclinical hypothyroidism. The thyroid 
hormone deficiency in obese patients, particularly the subclinical pattern, may be 
undiagnosed. Subsequently, these obese patients will continue gaining weight and will 
have a disordered lipid profile, thus causing the obesity/thyroid correlation to a full 
circle. 
Some follicular cells, in the semi-thin sections of group (II), showed pyknotic 
nuclei and vacuolated cytoplasm. The cytoplasmic vacuolation and nuclear pyknosis 
are signs of cellular degeneration and necrosis and they may be a consequence of the 
lipotoxicity associated with obesity. In this context; Engin (2017) [16] stated that 
when packaging of high amounts of lipids into fat droplets fails, chronic elevation of 
fatty acids in blood will occur and may progress to noxious levels within non-adipose 
tissues. Weinberg (2006) [45] added that the toxicity, in case of obesity, is derived 
mainly from NEFA (long-chain non-esterified fatty acids) and their products such as 
ceramides and diacylglycerols that accumulate due to the unsuccessful esterification 
and breakdown of the triglycerides [40]. Numerous pathways are included in the acute 
and chronic cellular effects of excess NEFA. They differ in their contributions from 
cell to cell (Fig. 8) [45] . 
Furthermore, the ultrathin sections of group (II) rats exhibited disordered 
cellular ultrastructure. Thyroid follicles showed blunt apical surface with absent 
microvilli, irregular shrunken nuclei with dense chromatin, an apparent decrease in 
the number of ribosomes and secretory granules and markedly dilated endoplasmic 
reticulum (Er). Large intracellular vacuoles, large colloid droplets, and pleomorphic 
lysosomes were also noticed, and some mitochondria appeared swollen with damaged 
cristae. Our observations were in harmony with that of Shao et al., (2014) [42]. They 
reported that HFD led to a reduced number of microvilli and secretory vesicles and 
wider perinuclear gaps. Cisternae of Er were dilated and near to the basal pole. Nuclei 
were twisted, and their chromatin was condensed. 
In the cell, the Er is a fundamental organelle. It synthesizes the secretory 
proteins [18]. The ultrastructural dilatation in the Er always distinguishes “Er stress” 
[12], [19] & [47]. Schröder & Kaufman (2005) [41] stated that numerous 
environmental and genetic factors lead to “Er stress”. In “Er stress”, the dilatation 
occurred due to the aggregation of unfolded and misfolded proteins in the Er lumen. 
Growing evidence confirmed the engagement of “Er stress” in lipotoxicity induced by 
saturated long-chain fatty acids [10], and HFD prompted the enhancement of unfolded 
protein markers in the fatty tissue of rats [28]. So, the ER dilation may be associated 
with enhanced “Er stress” in thyrocytes induced by HFD feeding. In addition, the 
unfolding and misfolding of the proteins in the Er may be the cause of decreased 
serum TT4 and FT4 concentrations in HFD feeding. 
Interestingly, in the present study, some parafollicular cells in sections of 
group (II) rats, also exhibited pyknotic nuclei by light microscope. By electron 
microscope, these cells showed irregular shrunken nuclei with dense chromatin, 
multiple intracellular vacuoles, and mitochondria with damaged cristae. All these 
changes were reversed in group (III). Zienab  et al., (2018) [50] assumed a mutual 
interdependence between the follicular and parafollicular cells. So, thyroid gland 
disruptors affecting follicular cells could also affect the parafollicular cells due to the 
cellular interdependence. Similarly, Dadan et al., (2003) [13] hypothesized that the 
possible mechanisms involved in the parafollicular cells changes were in line with 
changes of follicular cells and increased (TSH) level in hypothyroid rats. Martín-
Lacave et al., (2009) [33] reported that parafollicular cells are principally known for 
synthesizing calcitonin, a hypo-calcemic hormone. Additionally, parafollicular cells 
may be included in the intrathyroidal regulation of follicular cells, proposing a 
possible inter-relationship between the two cell types. If this assumption is true, 
massive alterations induced by various factors in the follicular cells may also 
influence the parafollicular cells. 
In the present study, mast cells infiltration appeared in group (II) in between 
the follicles and in the loose connective tissue surrounding the thyroid gland. This 
finding was repealed in group (III). Żelechowska et al., (2018) [49] reported that 
multiple immune cell populations contribute to obesity patho-mechanisms and the 
induction of chronic inflammation. Mast cells number particularly increases in obese 
individuals. They secrete strong pro-inflammatory mediators, chemokines, and 
cytokines. Mast cells number is higher in adipose tissue of obese patients than that of 
lean individuals. Mast cells may take part in tissue inflammation by the production of 
interferon gamma (IFN-γ) and interleukin-6 (IL-6) [43]. Moreover, mast cells number 
is related to fibrosis, macrophage inflammation and endothelial activation of adipose 
tissue in obesity [14]. The aforementioned studies ensure that mast cell populations 
increased in adipose tissue of obese patients and mast cells secrete many substances 
that produce a state of tissue inflammation. Moreover, the present study ensured that 
the mast cells apparently increased in between the follicles and in the soft tissue 
around the thyroid gland. So, it could be assumed that mast cells, by their secretions, 
may also play a role in thyroid gland structural and functional alterations in obesity. 
In the current study, vacuolization of the colloid within the thyroid follicles 
was seen in the semithin sections of group (II). Wang et al., (2009) [44] depicted that 
extensive vacuolization of colloid in some follicles was due to increased endocytotic 
activity of the thyroid gland to release the stored hormones to compensate T3 and T4 
deficiency. They hypothesized that this vacuolization is due to increased serum 
(TSH).  
In the present study, examination of semithin sections of rats fed with HFD 
and treated with metformin (group III) showed a nearly normal follicular structure. 
The morphometric analysis also revealed a statistically significant reduction of the 
colloid area and an increase of the follicular cell height in group (III) as compared to 
group (II). Moreover, the ultrastructure of follicular cells exhibited rounded 
euchromatic nuclei and the cytoplasm contained moderately dilated Er, healthy 
mitochondria, apical microvilli, rounded lysosomes, ribosomes, and secretory 
granules but few small vacuoles could be seen. The lipid profile, serum TSH and 
thyroid hormones levels were also improved. The aforementioned observations 
pointed for the ameliorative effect of metformin on thyroid structure and function. Hu 
et al., (2017) [23] reported that rodents on metformin treatment manifested relatively 
lower body weight and symptoms like diarrhoea and irritability with a notable 
elevation in FT3 and FT4. Serum TSH level was also significantly decreased. The 
previous data clarify that metformin can alter thyroid function and induce a state of 
hyperthyroidism. Karimifar et al., (2014) [27] added that metformin could produce a 
‘buffer effect’ on TSH level in blood. Thyroid stimulating hormone returned to the 
middle of its normal range upon metformin administration. Moreover, Krysiak & 
Okopien, (2011) [30] suggested that metformin may change the activity of 
hypothalamic–pituitary–thyroid axis at the peripheral tissues level by its direct 
influence on the thyroid gland itself.  
Additionally, Anil et al., (2016) [4] stated that metformin treatment 
significantly diminished thyroid volume and nodule size by ultrasonography. 
Ittermann et al., (2013) [23] also reported that patients with diabetes mellitus tended 
to have a significantly increased thyroid volume and a greater frequency of incident 
goitre and nodules. Besides, diabetic patients on metformin therapy had a relatively 
reduced thyroid volume with a lower risk for development of thyroid nodules. The 
aforementioned studies demonstrated that metformin may have a (TSH)-lowering 
effect and could increase thyroid hormone secretion by the thyroid gland. The current 
study added that metformin had also an ameliorative effect on the thyroid gland 
structure. In other words, metformin may correct the structural and functional changes 
that occur in thyroid gland in obesity. However, more associated studies are necessary 
to analyse the pathophysiological basis of metformin action in thyroid gland of obese 
patients. 
CONCLUSIONS 
Obesity induced by HFD in female rats provoked deleterious structural and 
functional changes in the thyroid gland, particularly at the ultrastructural level. These 
changes were ameliorated by metformin therapy. Further studies are needed to clarify 
the underlying mechanisms of metformin action on the thyroid gland in obese female 
rats.   
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Table 1. General and biochemical parameters  
 Group (I) Group (II) Group (III) 
Body weight (gm) 340.13+2.16             440.49+0.97* 267.2+0.62** 
Waist circumference 
(cm) 
13.2+13.7 20.01+19.8 9.94+8.9 
Serum cholesterol 
(mg/dl) 




74.84+2.91 145.3+2.98* 83.27+3.1** 
Serum HDL (mg/dl) 35.29+2.71 53.88+2.24* 40.78+1.83** 
Serum LDL (mg/dl) 68.54+2.40 97.08+2.72* 74.2+2.29** 
(pmol/l)3 Free T 6.38+0.24 6.15+0.21* 12.92+0.45** 
(pmol/l)4 Free T 37.33+0.32 29.25+0.21* 43.4+0.32** 
TSH (mIU/l) 0.04+0.47 0.07*+1.18 0.04**+0.64 
All results are expressed as mean ± SD. P value = probability of chance, P< 0.05 is significant; 
*indicates a significant difference. (*P<0.05 vs group I, ** P<0.005 vs group II, ANOVA test). 
 
 
Table 2. The colloid area (um2) and the follicular cell height (um) 
of the thyroid follicles in the different studied groups. 
 
 Group (I) Group (II) Group (III) 
Colloid area (um2) 1818.21+48094.2 *2040.96+110583.9 **3087.09+60246.64 






Data were stated as mean ± standard deviation, P value = probability of chance, P< 0.05 is significant; 




Figure 1. A histogram displaying; A) the body weight of the different groups along 
the study, B) the body weight and waist circumference of the different groups at the 
end of the study, C) the lipid profile of the different groups at the end of the study, D) 
the thyroid hormones levels of the different groups at the end of the study. 
Figure 2. Photomicrographs of sections of the thyroid gland of: A) control group 
(group I) displaying cuboidal follicular cells (arrow), parafollicular cells (arrow head), 
colloid (C), and capillary bed (thick arrow). B, C and D group II. B) displaying 
excessive amount of colloid, flattened follicular cells (arrow head), pyknotic nuclei 
(arrow), and mast cells infiltration (double arrow). C) displaying vacuolated 
cytoplasm in some follicular cells (arrow), disrupted basement membrane (arrow 
head), and parafollicular cells with pyknotic nuclei (thick arrow). There is variation in 
the density of colloid between follicles and also vacuolated colloid (C). Mast cells 
infiltration is seen (double arrow). D) displaying mast cells infiltration (arrow head) in 
the loose connective tissue surrounding the thyroid gland (L). (Toluidine blue X400) 
Figure 3. Photomicrographs of sections of the thyroid gland of group (III): A) 
displaying a near-normal follicular structure with cuboidal follicular cells having 
rounded vesicular nuclei (thick arrow) and some cells are still flat with oval vesicular 
nuclei (f). Few cells still show vacuolated cytoplasm (arrow). The colloid (C) is 
moderate in amount. Parafollicular cells (arrow head) mostly exhibit a near-normal 
structure with large rounded vesicular nuclei. Capillary beds are seen in between the 
follicles (double arrow). B) displaying no mast cells infiltration between the follicles 
and in the loose connective tissue (L) surrounding the thyroid gland (Toluidine blue 
X400) 
Figure 4. Electron micrographs of the thyroid follicle of group I (control) showing: 
A) follicular cells (F), the basement membrane (arrow) and the colloid (C). 
Endothelial (E) cell is also marked (X1500), B) A higher magnification of the 
previous micrograph showing an euchromatic nucleus (N), apical microvilli (m), 
plasmalemma (double arrow), mitochondria (arrow), lysosomes (L), multiple 
secretory granules (S) and endoplasmic reticulum (arrow head) (X3000), C) A 
parafollicular cell (P) is seen with large euchromatic nucleus (N), multiple 
cytoplasmic granules (arrow) and mitochondria (arrow head). Endothelium of 
adjacent blood capillary (E), a follicular cell (F), and the follicular colloid (C) are seen 
(X2000).  
Figure 5. Electron micrographs of sections of the thyroid gland of group II showing 
A) flattened follicular cells (F), blunt apical surface (arrow) and the follicular colloid 
(C). Blood capillaries with red blood cells (R) are seen between the follicles (X1200), 
B) follicular cells (F) with irregular dense shrunken nuclei and dilated endoplasmic 
reticulum. Endothelial cells (E) of blood capillaries with red blood cells (R) and A 
parafollicular cell (P) are seen (X1200), C) A higher magnification displaying 
irregular dense shrunken nuclei (N), dilated endoplasmic reticulum (r), large 
intracellular vacuoles (arrow head), large colloid droplets (arrow) and multiple 
lysosomes (L) (X2500), D) A parafollicular cell (P) with irregular shrunken nucleus 
(N), multiple cytoplasmic vacuoles (arrow) and damaged mitochondria (arrow head).  
The follicular cells (F) with dilated endoplasmic reticulum and swollen damaged 
mitochondria (m) and the colloid (C) are seen (X2000).  
Figure 6. Electron micrographs of sections of the thyroid gland of group III showing: 
A) nearly normal follicular cells (F) with central spherical euchromatic nuclei, 
multiple lysosomes and some small vacuoles (arrow head). Red blood cell (R) is also 
seen (X1500), B) A higher magnification displaying the euchromatic nucleus (N), 
moderately dilated endoplasmic reticulum (r), mitochondria (arrow), multiple 
secretory granules (S) and lysosomes (L) (X3000), C) follicular cells having oval 
nuclei (N), moderately dilated endoplasmic reticulum (r), and small vacuoles (arrow 
head) (X1500), D) a parafollicular cell (P) having a near-normal euchromatic nucleus 
and its characteristic multiple cytoplasmic granules (arrow), (X1500), C = colloid. 
Figure 7. A histogram displaying; A) the colloid area of the thyroid follicles and B) 
the follicular cell height of the thyroid follicles in the different inspected groups. 
Figure 8. Illustrative diagram for cellular pathways of lipotoxicity (Quoted from 
Weinberg, 2006).  








